Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(C8-R)-hydantocidin 5'-phosphate is a synthetic small molecule belonging to the class of pentose phosphates. It is an experimental compound structurally related to hydantocidin, a natural product known for its herbicidal and enzyme inhibitory properties. The compound features a phosphate group at the 5' position and specific stereochemistry at the C8 carbon in the R configuration. It has been studied as an inhibitor of adenylosuccinate synthetase, an enzyme involved in purine biosynthesis, by mimicking substrate or intermediate states and interfering with enzymatic activity[4][6]. Its primary use has been in biochemical research rather than clinical development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (C8-R)-hydantocidin 5'-phosphate.